US Stock MarketDetailed Quotes

IMUX Immunic

Watchlist
  • 1.050
  • -0.020-1.87%
Close Dec 24 13:00 ET
  • 1.050
  • 0.000-0.03%
Post 16:24 ET
94.58MMarket Cap-0.85P/E (TTM)

Immunic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
9.15%25.73M
-8.82%22.81M
-12.37%23.88M
14.68%99.22M
-4.01%23.38M
17.17%23.57M
21.40%25.02M
27.13%27.25M
-5.62%86.52M
12.14%24.36M
Selling and administrative expenses
15.42%4.36M
16.68%4.49M
19.99%5.15M
4.88%16.01M
13.11%4.1M
5.45%3.77M
-5.48%3.85M
7.47%4.29M
14.76%15.26M
8.35%3.62M
-General and administrative expense
15.42%4.36M
16.68%4.49M
19.99%5.15M
4.88%16.01M
13.11%4.1M
5.45%3.77M
-5.48%3.85M
7.47%4.29M
14.76%15.26M
8.35%3.62M
Research and development costs
7.95%21.37M
-13.46%18.32M
-18.41%18.74M
16.78%83.22M
-7.00%19.28M
19.71%19.8M
28.02%21.17M
31.63%22.96M
16.59%71.26M
12.83%20.74M
Operating profit
-9.15%-25.73M
8.82%-22.81M
12.37%-23.88M
-14.68%-99.22M
4.01%-23.38M
-17.17%-23.57M
-21.40%-25.02M
-27.13%-27.25M
5.62%-86.52M
-12.14%-24.36M
Net non-operating interest income expense
1.31%776K
3.10%998K
48.38%1.19M
195.39%3.08M
-22.49%541K
233.04%766K
813.21%968K
11,328.57%800K
1,477.27%1.04M
4,553.33%698K
Non-operating interest income
1.31%776K
3.10%998K
48.38%1.19M
195.39%3.08M
-22.49%541K
233.04%766K
813.21%968K
11,328.57%800K
1,477.27%1.04M
4,553.33%698K
Other net income (expense)
1,562.86%582K
707.41%436K
-684.39%-6.89M
107.26%2.54M
103.86%1.27M
102.62%35K
103.87%54K
90.16%1.18M
-2,495.10%-34.93M
-6,398.46%-32.82M
Gain on sale of security
----
----
---4.8M
----
----
----
----
----
----
----
Special income (charges)
----
----
----
--0
----
----
----
----
---32.97M
----
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--32.97M
----
Other non- operating income (expenses)
1,562.86%582K
707.41%436K
-277.61%-2.09M
229.39%2.54M
718.06%1.27M
102.62%35K
103.87%54K
90.16%1.18M
-45.62%-1.96M
-70.25%155K
Income before tax
-7.02%-24.37M
10.91%-21.38M
-17.06%-29.58M
22.25%-93.61M
61.80%-21.57M
-7.28%-22.77M
-9.58%-24M
-21.45%-25.27M
-29.55%-120.41M
-166.58%-56.47M
Income tax
Net income
-7.02%-24.37M
10.91%-21.38M
-17.06%-29.58M
22.25%-93.61M
61.80%-21.57M
-7.28%-22.77M
-9.58%-24M
-21.45%-25.27M
-29.55%-120.41M
-166.58%-56.47M
Net income continuous Operations
-7.02%-24.37M
10.91%-21.38M
-17.06%-29.58M
22.25%-93.61M
61.80%-21.57M
-7.28%-22.77M
-9.58%-24M
-21.45%-25.27M
-29.55%-120.41M
-166.58%-56.47M
Minority interest income
Net income attributable to the parent company
-7.02%-24.37M
10.91%-21.38M
-17.06%-29.58M
22.25%-93.61M
61.80%-21.57M
-7.28%-22.77M
-9.58%-24M
-21.45%-25.27M
-29.55%-120.41M
-166.58%-56.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-7.02%-24.37M
10.91%-21.38M
-17.06%-29.58M
22.25%-93.61M
61.80%-21.57M
-7.28%-22.77M
-9.58%-24M
-21.45%-25.27M
-29.55%-120.41M
-166.58%-56.47M
Basic earnings per share
52.94%-0.24
61.11%-0.21
48.28%-0.3
44.18%-2.11
70.37%-0.48
26.09%-0.51
25.00%-0.54
21.62%-0.58
3.82%-3.78
-170.00%-1.62
Diluted earnings per share
52.94%-0.24
61.11%-0.21
48.28%-0.3
44.18%-2.11
70.37%-0.48
26.09%-0.51
25.00%-0.54
21.62%-0.58
3.82%-3.78
-170.00%-1.62
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 9.15%25.73M-8.82%22.81M-12.37%23.88M14.68%99.22M-4.01%23.38M17.17%23.57M21.40%25.02M27.13%27.25M-5.62%86.52M12.14%24.36M
Selling and administrative expenses 15.42%4.36M16.68%4.49M19.99%5.15M4.88%16.01M13.11%4.1M5.45%3.77M-5.48%3.85M7.47%4.29M14.76%15.26M8.35%3.62M
-General and administrative expense 15.42%4.36M16.68%4.49M19.99%5.15M4.88%16.01M13.11%4.1M5.45%3.77M-5.48%3.85M7.47%4.29M14.76%15.26M8.35%3.62M
Research and development costs 7.95%21.37M-13.46%18.32M-18.41%18.74M16.78%83.22M-7.00%19.28M19.71%19.8M28.02%21.17M31.63%22.96M16.59%71.26M12.83%20.74M
Operating profit -9.15%-25.73M8.82%-22.81M12.37%-23.88M-14.68%-99.22M4.01%-23.38M-17.17%-23.57M-21.40%-25.02M-27.13%-27.25M5.62%-86.52M-12.14%-24.36M
Net non-operating interest income expense 1.31%776K3.10%998K48.38%1.19M195.39%3.08M-22.49%541K233.04%766K813.21%968K11,328.57%800K1,477.27%1.04M4,553.33%698K
Non-operating interest income 1.31%776K3.10%998K48.38%1.19M195.39%3.08M-22.49%541K233.04%766K813.21%968K11,328.57%800K1,477.27%1.04M4,553.33%698K
Other net income (expense) 1,562.86%582K707.41%436K-684.39%-6.89M107.26%2.54M103.86%1.27M102.62%35K103.87%54K90.16%1.18M-2,495.10%-34.93M-6,398.46%-32.82M
Gain on sale of security -----------4.8M----------------------------
Special income (charges) --------------0-------------------32.97M----
-Less:Impairment of capital assets --------------0------------------32.97M----
Other non- operating income (expenses) 1,562.86%582K707.41%436K-277.61%-2.09M229.39%2.54M718.06%1.27M102.62%35K103.87%54K90.16%1.18M-45.62%-1.96M-70.25%155K
Income before tax -7.02%-24.37M10.91%-21.38M-17.06%-29.58M22.25%-93.61M61.80%-21.57M-7.28%-22.77M-9.58%-24M-21.45%-25.27M-29.55%-120.41M-166.58%-56.47M
Income tax
Net income -7.02%-24.37M10.91%-21.38M-17.06%-29.58M22.25%-93.61M61.80%-21.57M-7.28%-22.77M-9.58%-24M-21.45%-25.27M-29.55%-120.41M-166.58%-56.47M
Net income continuous Operations -7.02%-24.37M10.91%-21.38M-17.06%-29.58M22.25%-93.61M61.80%-21.57M-7.28%-22.77M-9.58%-24M-21.45%-25.27M-29.55%-120.41M-166.58%-56.47M
Minority interest income
Net income attributable to the parent company -7.02%-24.37M10.91%-21.38M-17.06%-29.58M22.25%-93.61M61.80%-21.57M-7.28%-22.77M-9.58%-24M-21.45%-25.27M-29.55%-120.41M-166.58%-56.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -7.02%-24.37M10.91%-21.38M-17.06%-29.58M22.25%-93.61M61.80%-21.57M-7.28%-22.77M-9.58%-24M-21.45%-25.27M-29.55%-120.41M-166.58%-56.47M
Basic earnings per share 52.94%-0.2461.11%-0.2148.28%-0.344.18%-2.1170.37%-0.4826.09%-0.5125.00%-0.5421.62%-0.583.82%-3.78-170.00%-1.62
Diluted earnings per share 52.94%-0.2461.11%-0.2148.28%-0.344.18%-2.1170.37%-0.4826.09%-0.5125.00%-0.5421.62%-0.583.82%-3.78-170.00%-1.62
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+7.81%
Tesla
TSLA
+7.36%
MARA Holdings
MARA
+4.68%
Coinbase
COIN
+4.28%
Amazon
AMZN
+1.77%

Unlock the Full List